Company: BLLN
Filing Date: 2025-06-20
Form Type: DRS
Source: 0000950123-25-006095
Chunk: 142

Company: BillionToOne, Inc.
Filing Date: 2025-06-20
Form: DRS
Chunk 142
---
 accounts payable and other accrued expenses due to increased testing volumes and timing of payments and non-cashcharges of $17.0 million primarily consisting of stock-based compensation, depreciation and amortization, amortization of operating right-of-useassets, change in fair value of 2022 Convertible Notes which were partially offset by the gain on extinguishment of debt. Investing activities Net cash provided by investing activities for the year ended December 31, 2023 of $82.8 million was the result of $90.0 million proceeds from maturities of certificates of deposit, partially offset by $6.2 million in purchases of property and equipment and $1.0 million deposits paid for financing leases. Net cash used by investing activities for the year ended December 31, 2024 of $5.4 million was primarily the result of $5.4 million in purchases of property and equipment. Financing activities Net cash provided by financing activities for the year ended December 31, 2023 of $13.4 million was the result of $15.0 million in proceeds from issuance of debt and $0.4 million in proceeds from exercise of stock options, partially offset by $2.1 million of principal payments on finance lease liabilities. Net cash provided by financing activities for the year ended December 31, 2024 of $141.0 million was the result of $130.0 million in proceeds from Series D redeemable convertible preferred stock, $49.8 million in net 107

proceeds from issuance of debt, $1.1 million in proceeds from exercise of stock options, partially offset by $36.7 million repayment of debt upon extinguishment and the related exit
fee, $2.4 million principal payments on finance lease liabilities and $0.5 million repurchase of common stock outstanding.

Contractual obligations and commitments

Operating lease commitments. Our operating lease commitments primarily include our labs and corporate offices. As of December 31, 2024,
we had fixed lease payment obligations of $76.6 million, with $8.8 million to be paid within 12 months and the remainder thereafter.

Finance lease commitments. Our finance lease commitments primarily relate to equipment used in our labs. As of December 31, 2024, we had fixed lease payment obligations of $2.8 million, with $1.9 million to be paid within 12 months and the
remainder thereafter.

For additional discussion on our leases, see Note 8 to our financial statements included elsewhere in this prospect